Cargando…
Fc γ receptor compositional heterogeneity: Considerations for immunotherapy development
The antibody-binding crystallizable fragment (Fc) γ receptors (FcγRs) are expressed by leukocytes and activate or suppress a cellular response once engaged with an antibody-coated target. Therapeutic mAbs that require FcγR binding for therapeutic efficacy are now frontline treatments for multiple di...
Autor principal: | Barb, Adam W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7948983/ https://www.ncbi.nlm.nih.gov/pubmed/33172893 http://dx.doi.org/10.1074/jbc.REV120.013168 |
Ejemplares similares
-
The role of PLCγ2 in immunological disorders, cancer, and neurodegeneration
por: Jackson, Jacob T., et al.
Publicado: (2021) -
The therapeutic potential of inhibiting PPARγ phosphorylation to treat type 2 diabetes
por: Frkic, Rebecca L., et al.
Publicado: (2021) -
Regulation of Wnt receptor activity: Implications for therapeutic development in colon cancer
por: Zhong, Zhendong A., et al.
Publicado: (2021) -
Is γ-secretase a beneficial inactivating enzyme of the toxic APP C-terminal fragment C99?
por: Checler, Frédéric, et al.
Publicado: (2021) -
Adaptation of influenza viruses to human airway receptors
por: Thompson, Andrew J., et al.
Publicado: (2020)